176 related articles for article (PubMed ID: 7673015)
1. The tumor volume and clonogen number relationship: tumor control predictions based upon tumor volume estimates derived from computed tomography.
Johnson CR; Thames HD; Huang DT; Schmidt-Ullrich RK
Int J Radiat Oncol Biol Phys; 1995 Sep; 33(2):281-7. PubMed ID: 7673015
[TBL] [Abstract][Full Text] [Related]
2. The influence of quantitative tumor volume measurements on local control in advanced head and neck cancer using concomitant boost accelerated superfractionated irradiation.
Johnson CR; Khandelwal SR; Schmidt-Ullrich RK; Ravalese J; Wazer DE
Int J Radiat Oncol Biol Phys; 1995 Jun; 32(3):635-41. PubMed ID: 7790249
[TBL] [Abstract][Full Text] [Related]
3. Accelerated superfractionated radiotherapy with concomitant boost for locally advanced head-and-neck squamous cell carcinomas.
Morris MM; Schmidt-Ullrich RK; DiNardo L; Manning MA; Silverman L; Clay L; Johnson CR; Amir C
Int J Radiat Oncol Biol Phys; 2002 Mar; 52(4):918-28. PubMed ID: 11958884
[TBL] [Abstract][Full Text] [Related]
4. [SIB-IMRT radiotherapy given concomitantly with cisplatin for locally advanced squamous cell head and neck cancer (SCHNC). Evaluation of the early results and toxicity].
Kiprian D; Jarząbski A; Pawłowska B; Michalski W; Kawecki A
Otolaryngol Pol; 2011 Sep; 65(5 Suppl):117-25. PubMed ID: 22000261
[TBL] [Abstract][Full Text] [Related]
5. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results.
Lauve A; Morris M; Schmidt-Ullrich R; Wu Q; Mohan R; Abayomi O; Buck D; Holdford D; Dawson K; Dinardo L; Reiter E
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):374-87. PubMed ID: 15380569
[TBL] [Abstract][Full Text] [Related]
6. Impact of tumor control and presence of visible necrosis in head and neck cancer patients treated with radiotherapy or radiochemotherapy.
Kuhnt T; Mueller AC; Pelz T; Haensgen G; Bloching M; Koesling S; Schubert J; Dunst J
J Cancer Res Clin Oncol; 2005 Nov; 131(11):758-64. PubMed ID: 16088405
[TBL] [Abstract][Full Text] [Related]
7. [Role of 18FDG-PET/CT in the management and gross tumor volume definition for radiotherapy of head and neck cancer; single institution experiences based on long-term follow-up].
Hideghéty K; Cserháti A; Besenyi Z; Zag L; Gaál S; Együd Z; Mózes P; Szántó E; Csenki M; Rusz O; Varga Z; Dobi Á; Maráz A; Pávics L; Lengyel Z
Magy Onkol; 2015 Jun; 59(2):103-10. PubMed ID: 26035157
[TBL] [Abstract][Full Text] [Related]
8. Is image registration of fluorodeoxyglucose-positron emission tomography/computed tomography for head-and-neck cancer treatment planning necessary?
Fried D; Lawrence M; Khandani AH; Rosenman J; Cullip T; Chera BS
Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):748-54. PubMed ID: 22414285
[TBL] [Abstract][Full Text] [Related]
9. Can pretreatment computed tomography findings predict local control in T3 squamous cell carcinoma of the glottic larynx treated with radiotherapy alone?
Lee WR; Mancuso AA; Saleh EM; Mendenhall WM; Parsons JT; Million RR
Int J Radiat Oncol Biol Phys; 1993 Mar; 25(4):683-7. PubMed ID: 8454487
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance and predictive performance of volume-based parameters of F-18 FDG PET/CT in squamous cell head and neck cancers.
Sager S; Asa S; Yilmaz M; Uslu L; Vatankulu B; Halaç M; Sönmezoglu K; Kanmaz B
J Cancer Res Ther; 2014; 10(4):922-6. PubMed ID: 25579529
[TBL] [Abstract][Full Text] [Related]
11. Dose painting by numbers based on retrospectively determined recurrence probabilities.
Grönlund E; Johansson S; Montelius A; Ahnesjö A
Radiother Oncol; 2017 Feb; 122(2):236-241. PubMed ID: 27707505
[TBL] [Abstract][Full Text] [Related]
12. Influence of the hypoxic subvolume on the survival of patients with head and neck cancer.
Stadler P; Becker A; Feldmann HJ; Hänsgen G; Dunst J; Würschmidt F; Molls M
Int J Radiat Oncol Biol Phys; 1999 Jul; 44(4):749-54. PubMed ID: 10386631
[TBL] [Abstract][Full Text] [Related]
13. Randomized phase I/II trial of two variants of accelerated fractionated radiotherapy regimens for advanced head and neck cancer: results of RTOG 88-09.
Fu KK; Clery M; Ang KK; Byhardt RW; Maor MH; Beitler JJ
Int J Radiat Oncol Biol Phys; 1995 Jun; 32(3):589-97. PubMed ID: 7790243
[TBL] [Abstract][Full Text] [Related]
14. Geometric analysis of loco-regional recurrences in relation to pre-treatment hypoxia in patients with head and neck cancer.
Boeke S; Thorwarth D; Mönnich D; Pfannenberg C; Reischl G; La Fougère C; Nikolaou K; Mauz PS; Paulsen F; Zips D; Welz S
Acta Oncol; 2017 Nov; 56(11):1571-1576. PubMed ID: 28891398
[TBL] [Abstract][Full Text] [Related]
15. Dose, volume, and tumor control prediction in primary radiotherapy of non-small-cell lung cancer.
Willner J; Baier K; Caragiani E; Tschammler A; Flentje M
Int J Radiat Oncol Biol Phys; 2002 Feb; 52(2):382-9. PubMed ID: 11872283
[TBL] [Abstract][Full Text] [Related]
16. Primary tumor volume is an important predictor of clinical outcomes among patients with locally advanced squamous cell cancer of the head and neck treated with definitive chemoradiotherapy.
Strongin A; Yovino S; Taylor R; Wolf J; Cullen K; Zimrin A; Strome S; Regine W; Suntharalingam M
Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1823-30. PubMed ID: 21549516
[TBL] [Abstract][Full Text] [Related]
17. Impact of primary tumor-specific growth rate on treatment failure for nonoropharyngeal head and neck cancers.
Roldan CS; Chen JJ; Fareed MM; Hameed MY; Churilla TM; Lango MN; Galloway TJ
Laryngoscope; 2020 Oct; 130(10):2378-2384. PubMed ID: 31714626
[TBL] [Abstract][Full Text] [Related]
18. Comparison of PET and CT radiomics for prediction of local tumor control in head and neck squamous cell carcinoma.
Bogowicz M; Riesterer O; Stark LS; Studer G; Unkelbach J; Guckenberger M; Tanadini-Lang S
Acta Oncol; 2017 Nov; 56(11):1531-1536. PubMed ID: 28820287
[TBL] [Abstract][Full Text] [Related]
19. Approximation of head and neck cancer volumes in contrast enhanced CT.
Dejaco D; Url C; Schartinger VH; Haug AK; Fischer N; Riedl D; Posch A; Riechelmann H; Widmann G
Cancer Imaging; 2015 Sep; 15():16. PubMed ID: 26419914
[TBL] [Abstract][Full Text] [Related]
20. Usefulness of tumor volumetry as a prognostic factor of survival in head and neck cancer.
Kurek R; Kalogera-Fountzila A; Muskalla K; Dafni U; Schnabel T; Kober B; Röddiger S; Martin T; Fountzilas G; Zamboglou N
Strahlenther Onkol; 2003 May; 179(5):292-7. PubMed ID: 12740655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
